News
A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease
FDA approved veligrotug (Lumvoa) for both active and chronic thyroid eye disease — a first. Here's who qualifies, what the evidence shows, and what changes for the 50,000–100,000 Americans affected annually.
→
Measles Exposure Confirmed at Grand Teton National Park as Officials Release Exact Dates and Locations
Wyoming confirmed measles at Grand Teton National Park. Exposure at Colter Bay restaurants June 17–20 and Jackson Target June 25. Here's who is at risk and what to do.
→
Imported Tobacco Has Been Operating Under Lower FDA Standards Than Domestic Products
Imported tobacco faces lower FDA oversight than domestic products. A new proposed rule would close the regulatory asymmetry. Here's what the gap is and what would change.
→
